𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of p27(Kip1)CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer

✍ Scribed by Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua

Publisher
Springer Netherlands
Year
2007
Tongue
English
Weight
341 KB
Volume
39
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of p27Kip1 and cyclin D1 prot
Expression of p27Kip1 and cyclin D1 proteins is inversely correlated and is associated with poor clinical outcome in human gastric cancer
✍ Han, Sehwan; Kim, Hong-Yong; Park, Kyeongmee; Lee, Myung-Soo; Kim, Hong-Joo; Kim πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 318 KB πŸ‘ 2 views

Background and Objectives: p27Kip1 is an inhibitor of cyclindependent kinases and is speculated to be a potential prognostic indicator in numerous human cancers. We investigated expression of p27Kip1 along with cyclin D1 in gastric cancer to estimate the clinical utility of p27Kip1. Methods: Immunoh

Cancer-specific survival and predictors
Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy
✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme